Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $16.2750 (-0.18%) ($16.2750 - $16.2750) on Tue. Jul. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.72% (three month average) | RSI | 62 | Latest Price | $16.2750(-0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 6.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWC(58%) IWO(55%) IWM(54%) IBUY(52%) | Factors Impacting EDIT price | EDIT will decline at least -3.36% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-9%) TBT(-9%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.36% (StdDev 6.72%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $16.58(-1.84%) | 10 Day Moving Average | $16.13(0.9%) | 20 Day Moving Average | $14.95(8.86%) | To recent high | -6.6% | To recent low | 63.8% | Market Cap | $1.011b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |